Search Results 81-90 of 17210 for peptide protocols

  1. A Study to Evaluate Injectafer® as Treatment for Heart Failure with Iron Deficiency - Mayo Clinic

    Sponsor Protocol Number: 1VIT15043 ... Guidelines differ from study to study, and ... For patients in normal sinus rhythm: N-terminal-probrain natriuretic peptide ...

  2. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight ...

  3. A Study Of LY2951742 In Participants With Chronic Cluster Headache - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. ... Current use or any prior exposure to any calcitonin-gene-related peptide ...

  4. Study To Evaluate The Safety And Effectiveness Of IW-1973 Dosing Over 12 Weeks In Patients With Congestive Heart Failure With Preserved Ejection Fraction - Mayo Clinic

    Sponsor Protocol Number: C1973-204 ... Guidelines differ from study to study, and identify who can or cannot participate. ... Elevated B-type natriuretic peptide ( ...

  5. A Study of Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure that has Preserved Ejection Fraction - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Publications - Maliha Zahid, M.B.B.S., Ph.D. - Mayo Clinic

    Novel Lung Cell-Penetrating Peptide Targets Alveolar Epithelial Type II Cells, Basal Cells, and Ionocytes. ... Cell-Penetrating Peptides ... Modified BFM protocol ...

  7. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. ... peptide of \<0.6 ng/mL 3. Subjects on any other ... protocol 46 ...

  8. Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients - Mayo Clinic

    Sponsor Protocol Number: DQB101US ... Guidelines differ from study to study, and identify who can or cannot participate. ... Deamidated gliadin peptide-IgA [DGP-IgA] ...

  9. A Study Comparing The Effectiveness And Safety Of The Morning Injection Of Toujeo Versus Lantus In Patients With Type 1 Diabetes Mellitus - Mayo Clinic

    Sponsor Protocol Number: LPS14587 ... Guidelines differ from study to study, and identify who can or cannot participate. ... Fasting c-peptide ≥0.3 nmol/L as per ...

  10. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. ... Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to ...